Drugs / Infusate 2.0
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05965934 | Jul 2023 → Dec 2024 | heart failure | Sequana Medical N.V. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Infusate 2.0 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05965934 ↗ |
| Route | Other | “Direct Sodium Removal via peritoneal ultrafiltration using Infusate 2.0” NCT05965934 ↗ |